Category: BioTech

BBRY NASDAQ BBRY Blackberry
BioTech

Hot Stocks: BlackBerry Ltd (NASDAQ:BBRY), Comtech Telecomm. Corp. (NASDAQ:CMTL), Cempra Inc (NASDAQ:CEMP), Aaron’s, Inc. (NYSE:AAN)

BlackBerry (NASDAQ:BBRY) was upgraded by investment analysts at Oppenheimer from an “underperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Analyst RN reports. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -3.28% in last session and finished the day at $ 7.67. Traded volume was 150.00 million shares in the last session and the average volume of the stock remained 16.18 … Continue reading Hot Stocks: BlackBerry Ltd (NASDAQ:BBRY), Comtech Telecomm. Corp. (NASDAQ:CMTL), Cempra Inc (NASDAQ:CEMP), Aaron’s, Inc. (NYSE:AAN)

John Bellich
Gilead Sciences GILD NASDAQ:GILD
Analysis, BioTech, Featured

Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Endocyte (NASDAQ:ECYT)’s shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings, American Banking and Market News reports. 13,778,961 shares changed hands during trading, an increase of 624% from the previous session’s volume of 1,903,723 shares. Endocyte, Inc. (NASDAQ:ECYT) stock performance was 61.91% in last session and finished the day at $ 6.62. Traded volume was 17,639,435 shares in … Continue reading Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Adam Keintzel
Avanir Pharmaceuticals
BioTech, Finance

Small Cap Losers: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Monster Worldwide (NYSE:MWW), Key Energy Services (NYSE:KEG), McEwen Mining (NYSE:MUX)

Shares of Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) soared 45.6% after the company announced that the U.S. District Court for the District of Delaware has ruled the patent infringement lawsuit against Par Pharmaceuticals, Inc. and Impax Laboratories, Inc. ( IPXL ) in its favor. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock performance was -6.63% in last session and finished the day at $4.65. Traded volume was 11.68million shares in … Continue reading Small Cap Losers: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Monster Worldwide (NYSE:MWW), Key Energy Services (NYSE:KEG), McEwen Mining (NYSE:MUX)

Kevin Long
BioTech

Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands at $5.00, off an earlier low of $4.25. The shares … Continue reading Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)

Colin Pettis
BioTech

Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Enzymotec Ltd (NASDAQ:ENZY) Conclude Final Patent Infringement Settlement

Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Acasti Pharma Inc (NASDAQ:ACST), a Neptune subsidiary, Sunday night announced that a final and binding patent infringement settlement and license agreement has been signed with Enzymotec Ltd. and Enzymotec Ltd(NASDAQ:ENZY) that resolves the International Trade Commission’s investigation of infringement of Neptune’s composition of matter patents, related federal court actions initiated by Neptune against Enzymotec and its distributors, and various patent review … Continue reading Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Enzymotec Ltd (NASDAQ:ENZY) Conclude Final Patent Infringement Settlement

Chris Lewis
BioTech

Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)

The American Despositary Receipts of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) edged up in recent pre-market trading on Monday after announcing over the weekend an agreement it has signed with Takeda Pharmaceutical for the marketing and sale of Rasagiline in Japan. Rasagiline is a treatment for Parkinson’s Disease developed by TEVA and has been approved in over 40 countries. TEVA closed at $48.69 on Friday in … Continue reading Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)

Ryan Holtz